Henry Schein, Inc. (HSIC) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Core Insights - The company's recent results were below expectations, leading to initial pressure on the stock price, which has since recovered to pre-release levels [1] - Investor communication has focused on initiatives to accelerate earnings and general expectations beyond 2025 [2] Financial Performance - The company experienced a temporary decline in stock price following the release of results, but it has rebounded to previous levels, indicating investor confidence [1] - Ongoing discussions with investors have aimed to clarify the company's strategies for future earnings growth [2]